Tuesday, April 22, 2025

"Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years"

From the Associated Press, April 22:

Swiss pharmaceuticals powerhouse Roche announced Monday it plans to invest $50 billion in the United States over the next five years, creating 12,000 jobs.

The Basel-based company, whose array of products includes cancer medicines and multiple sclerosis treatment Ocrevus, said the investment would go toward high-tech research and development sites and new manufacturing facilities in places including California, Indiana, Massachusetts and Pennsylvania.

The announcement comes as U.S. President Donald Trump has urged foreign businesses to invest more in the United States, and announced sweeping tariffs earlier this month on imports as part of hopes to reduce a large U.S. trade deficit when it comes to sales of goods.

Before the Trump administration backed off its most stringent tariff plans, products imported from Switzerland had been set to face tariffs of 31% — more than the 20% tariffs on goods from the European Union. Switzerland is not a member of the 27-country bloc but is virtually surrounded by four EU countries....

....MUCH MORE

As noted exiting April 13's "Pharma CEOs alert President von der Leyen to risk of exodus to the US" on The European Federation of Pharmaceutical Industries and Associations:

These folks have clout.

Here's who "These folks" are:  

  • Abbvie
  • Almiral
  • Amgen
  • Astellas
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingleheim 
  • Bristol Myers Squibb
  • Dai Ichi Sankyo
  • Gilead
  • Grunenthal
  • GSK
  • Johnson&Johnson
  • LEO
  • Lilly
  • Merck
  • Novartis
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
  • Takeda 
  • Teva

And many more. My thought when seeing the membership list was: I have heard of these companies.